| Thyroid Disease |
1 |
0.66 |
| Hypothyroidism |
0 |
0.47 |
| Thyroiditis |
0 |
0.43 |
| Alopecia |
0 |
0.42 |
| Eosinophilia |
0 |
0.38 |
| Hashimoto Thyroiditis |
0 |
0.37 |
| Alopecia Areata |
0 |
0.33 |
| Artificial Intelligence |
0 |
0.33 |
| Healthcare and Medical Technology |
0 |
0.33 |
| Dermatitis |
0 |
0.31 |
| Corticosteroids |
0 |
0.24 |
| Cyclosporine |
0 |
0.24 |
| Steroids |
0 |
0.24 |
| Type 1 Diabetes Mellitus |
0 |
0.24 |
| Drug Reaction |
0 |
0.19 |
| Erythroderma |
0 |
0.19 |
| Dermatologic Surgery |
0 |
0.17 |
| Biopsy |
0 |
0.14 |
| Punch Biopsy |
0 |
0.14 |
| Biologic Therapy |
0 |
0.13 |
| Acute Liver Failure |
0 |
0.11 |
| Fatigue |
0 |
0.1 |
| Fever |
0 |
0.1 |
| Health Education and Counseling |
0 |
0.1 |
| Human Leukocyte Antigen |
0 |
0.1 |
| Liver |
0 |
0.1 |
| Liver Failure |
0 |
0.1 |
| Pruritus |
0 |
0.1 |
| Thyroid |
0 |
0.1 |
| Glucocorticoid |
0 |
0.08 |
| Human Herpesvirus 6 (HHV-6) |
0 |
0.08 |
| Intravenous Immunoglobulin (IVIG) |
0 |
0.08 |
| Renal Failure |
0 |
0.08 |
| Cardiovascular Imaging |
0 |
0.07 |
| Complete Blood Count |
0 |
0.07 |
| Heart Failure (HF) |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |
| Adrenal Insufficiency |
0 |
0.05 |
| Adverse Effects |
0 |
0.05 |
| Allergy |
0 |
0.05 |
| Anorexia Nervosa |
0 |
0.05 |
| Antibiotics |
0 |
0.05 |
| Anticonvulsant |
0 |
0.05 |
| Antigens |
0 |
0.05 |
| Antineoplastic Drug |
0 |
0.05 |
| Autoimmune Disease |
0 |
0.05 |
| Bipolar Disorder |
0 |
0.05 |
| Blood |
0 |
0.05 |
| Burns |
0 |
0.05 |
| Diabetes Mellitus |
0 |
0.05 |
| Eating Disorders |
0 |
0.05 |
| Echocardiography |
0 |
0.05 |
| Edema |
0 |
0.05 |
| Epilepsy |
0 |
0.05 |
| Face |
0 |
0.05 |
| Genetics |
0 |
0.05 |
| Genomic Medicine |
0 |
0.05 |
| Hair |
0 |
0.05 |
| Heart |
0 |
0.05 |
| Herpes Viruses |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Immunocompromise |
0 |
0.05 |
| Immunoglobulin A (IgA) |
0 |
0.05 |
| Intravenous |
0 |
0.05 |
| Kidney |
0 |
0.05 |
| Lymph Node |
0 |
0.05 |
| Lymphadenopathy |
0 |
0.05 |
| Monoclonal Antibody |
0 |
0.05 |
| Pancreas |
0 |
0.05 |
| Pathogenesis |
0 |
0.05 |
| Pituitary Gland |
0 |
0.05 |
| Plasma |
0 |
0.05 |
| Preventive Screening |
0 |
0.05 |
| Refractory |
0 |
0.05 |
| Respiratory Tract |
0 |
0.05 |
| Scalp |
0 |
0.05 |
| Skin Rash |
0 |
0.05 |
| Tissue |
0 |
0.05 |
| Vitiligo |
0 |
0.05 |
| Wound Management |
0 |
0.05 |